InnoCan Pharma (INNPF) Financial Statements

Compare

17 Followers

InnoCan Pharma Financial Overview

InnoCan Pharma's market cap is currently $21.33M. The company's EPS TTM is $; its P/E ratio is -6.72; InnoCan Pharma is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 24	Dec 22	Mar 22	Mar 21
Income Statement
Total Revenue	$ 29.44M	$ 13.66M	$ 2.56M	$ 196.00K	$ 8.00K
Gross Profit	$ 26.19M	$ 11.98M	$ 2.11M	$ 121.00K	$ 3.00K
Operating Income	$ -1.25M	$ 3.80M	$ -6.27M	$ -7.48M	$ -4.72M
EBITDA	$ 961.00K	$ -3.77M	$ -3.85M	$ -10.04M	$ -9.90M
Net Income	$ -1.83M	$ -4.70M	$ -3.89M	$ -10.06M	$ -15.18M
Balance Sheet
Cash & Short-Term Investments	$ 5.01M	$ 3.88M	$ 4.95M	$ 11.05M	$ 2.34M
Total Assets	$ 9.26M	$ 6.94M	$ 6.98M	$ 12.57M	$ 4.33M
Total Debt	$ 10.00K	$ 33.00K	$ 34.00K	$ 1.00K	$ 38.00K
Net Debt	$ -5.00M	$ -3.85M	$ -4.91M	$ -11.05M	$ -2.30M
Total Liabilities	$ 2.24M	$ 2.55M	$ 751.00K	$ 3.56M	$ 7.94M
Stockholders' Equity	$ 5.17M	$ 4.10M	$ 6.39M	$ 9.05M	$ -3.61M
Cash Flow
Free Cash Flow	$ -1.59M	$ -3.95M	$ -6.09M	$ -6.67M	$ -3.69M
Operating Cash Flow	$ -1.58M	$ -3.90M	$ -6.07M	$ -6.63M	$ -3.69M
Investing Cash Flow	$ 54.00K	$ -84.00K	$ -31.00K	$ -48.00K	$ 0.00
Financing Cash Flow	$ 2.70M	$ 2.92M	$ 125.00K	$ 15.30M	$ 4.02M

Currency in USD

InnoCan Pharma Earnings and Revenue History

Income Statement >

InnoCan Pharma Debt to Assets

Balance Sheet >

InnoCan Pharma Cash Flow

Cash Flow >

InnoCan Pharma Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >